Precigen shares jump after US FDA approves first therapy for rare respiratory disease – Reuters

1. Precigen shares jump after US FDA approves first therapy for rare respiratory disease  Reuters
2. US FDA approves Precigen’s immunotherapy for rare respiratory disease  Reuters
3. Precigen Stock Shot Through The Roof On Friday Morning – Here’s Why  Stocktwits
4. Papzimeos Approved for Recurrent Respiratory Papillomatosis  Medical Professionals Reference
5. Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial  BioPharma Dive

Continue Reading